Methadone Market Size

  • Report ID: 3793
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Methadone Market Size

Methadone Market size was over USD 172.86 million in 2024 and is poised to exceed USD 437.27 million by 2037, witnessing over 7.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of methadone is evaluated at USD 193.93 million.

The growth of the market is associated with the increasing prevalence of pain after a post-surgery treatment or treatment. The demand for methadone is driven by these pain-related issues. Methadone helps in reducing the deadly pain that takes place after a therapeutic or post-surgery treatment. As per a report from the U.S. Department of Health and Human Services, in 2019, around 20% of U.S. adults suffered from chronic diseases out of which 4% of adults felt chronic pain from the disease very hard.

Additionally, the growing number of people addicted to multiple opioids such as heroin, and morphine is also a significant factor that is anticipated to drive the growth of this market in the forecast period. Methadone helps an individual get rid of the addiction or dependency on heroin, morphine, or any other prescription painkillers. As per National Survey on Drug Use and Health, indicates that around 6 million adults globally are addicted to Heroin.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3793
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of methadone is evaluated at USD 193.93 million.

The methadone market size was over USD 172.86 million in 2024 and is poised to exceed USD 437.27 million by 2037, witnessing over 7.4% CAGR during the forecast period i.e., between 2025-2037. The growing demand for methadone rehabilitation of heroin addicts will drive the market growth.

North America industry is likely to account for largest revenue share of 42% by 2037, driven by increasing cases of drug addiction in the region.

The major players in the market are Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample